How many clinical trials are there for Radial Artery Occlusion?

PlainTrial tracks 1 US clinical trials for Radial Artery Occlusion, of which 1 are currently recruiting.

Which interventions appear most often on Radial Artery Occlusion trial records?

Rivaroxaban 15 MG Oral Tablet [Xarelto] is the most-linked intervention name on Radial Artery Occlusion records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Radial Artery Occlusion?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Radial Artery Occlusion: later-stage trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Radial Artery Occlusion trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Radial Artery Occlusion: 1 US clinical trial tracked, 1 recruiting.

Radial Artery Occlusion is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ottawa Heart Institute Research Corporation, running 1 of these trials.

Enrollment posture brief

Registry condition radial-artery-occlusion

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Radial Artery Occlusion

Radial Artery Occlusion lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Radial Artery Occlusion on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Radial Artery Occlusion is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 3 1,800 participants

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

Ottawa Heart Institute Research Corporation

NCT03630055

Phase Distribution

Phase	Trial count
Phase 3	1

Top Sponsors

Ottawa Heart Institute Research Corporation 1 trials

Named interventions

Most-linked intervention names on Radial Artery Occlusion records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Rivaroxaban 15 MG Oral Tablet [Xarelto] Drug

1 trials

US sites by state

Facility locations filed on Radial Artery Occlusion trials. A trial with sites in several states counts in each.

Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Radial Artery Occlusion page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Radial Artery Occlusion trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Ottawa Heart Institute Research Corporation sponsors the most Radial Artery Occlusion trials on record, review their full trial history before evaluating a specific study. See Ottawa Heart Institute Research Corporation's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Radial Artery Occlusion condition card totals 1 registered trials; most-linked intervention Rivaroxaban 15 MG Oral Tablet [Xarelto]; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.